GOVX GeoVax Labs, Inc.

GeoVax Labs, Inc. is a clinical-stage biotechnology company with a robust pipeline of human vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease.

$0.90  +0.09 (10.75%)
As of 02/01/2023 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/31/1997
Outstanding shares:  26,334,953
Average volume:  934,431
Market cap:   $19,780,183
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy